

AccuMix compounds patient-specific peptide and wellness prescriptions to your prescriber’s exact directions, under USP standards in ISO-classified cleanrooms. This page lists what we dispense today, what we are developing, and where six widely discussed peptides stand with FDA.
Peptides & wellness
Peptides are short chains of amino acids that can act as signaling molecules in the body. Evidence differs by peptide and use; your prescriber decides whether a therapy is appropriate and how it should be monitored.
AccuMix compounds patient-specific prescriptions only after receiving a valid prescription. Compounded medications are prepared under federal and state regulations and USP standards; they are not reviewed or approved by the FDA.
NAD+ — nicotinamide adenine dinucleotide, a coenzyme found in every cell.
Sermorelin — a 29-amino-acid analog of growth hormone–releasing hormone (GHRH).
Oxytocin nasal spray — a compounded intranasal form of the hormone oxytocin.
Aesthetic & Anti-Aging Blends — Custom topical and (where appropriate) injectable preparations intended to support collagen stimulation, skin tone/elasticity, and appearance-focused goals—prepared to the formula your prescriber orders.
In development: glutathione and GHK-Cu topical cream. Our team is completing formulation and testing work. We will list them here when they are available to dispense.
How it is prepared: Each prescription is compounded for an individual patient, in the dosage form your prescriber orders. Exact directions appear on your label.
Status as of October 2026. On July 23–24, 2026, FDA’s Pharmacy Compounding Advisory Committee voted to recommend six peptides for the list of bulk drug substances that 503A pharmacies may compound. That vote is a recommendation. FDA has not yet acted on it.
AccuMix does not compound or dispense these six peptides today, and we do not accept prescriptions or pre-orders for them. We are actively preparing the infrastructure so that we are ready if FDA accepts the committee’s recommendation. Dispensing will begin only if and when FDA permits it.
None of these peptides is an FDA-approved drug, and human clinical evidence for them is limited. Nothing on this page is a claim that they are safe or effective for any condition.
No. These peptides are not currently eligible for compounding by 503A pharmacies. We will not dispense them until FDA permits it.
The committee voted in July 2026 to recommend six peptides. Advisory votes are not binding. FDA must still decide, and has not announced a timeline.
We don’t know. It depends on FDA. We will update this page when the status changes. Providers who want an update can email info@accumixrx.com.
No. AccuMix is a licensed pharmacy. Everything we dispense is compounded for an individual patient on a prescription.
24-hour turnaround time.
from FDA-registered suppliers. A certificate of analysis is available for every API lot and every batch.
Your clinician may consider compounded peptide or wellness therapy when a commercial option isn’t suitable, a different dose/route is required, or as part of a personalized program targeting recovery, composition, skin health, energy, or longevity goals. Your prescriber determines eligibility, dose, and follow-up plan.
Patients: Ask your provider to send an eRx/fax to AccuMix Pharmacy.
Providers & Clinics: Send eRx/fax or request a pharmacist consult for dosage-form selection, concentration logistics, and documentation.
Follow label storage and handling (e.g., refrigeration for certain sterile products; protect from light if indicated). Keep out of reach of children and pets.
Other Products
Weight Management Compounding
Hormone Replacement Therapy
Peptide, Aesthetic & Wellness
Allergy Immunotherapy
Sexual Health
IV Therapy
Dermatology Compounding
Provider resources (quick reference)

FAQ
Our turnaround time is 24 hours. Delivery time depends on carrier and destination.
Compliance & disclosures
AccuMix operates as a 503A compounding pharmacy. We compound patient-specific medications after receipt of a valid prescription. Compounded medications are prepared under federal/state regulations and USP ⟨795⟩/⟨797⟩/⟨800⟩ standards; they are not reviewed or approved by the FDA. Availability of specific peptide/wellness compounds varies by state law, federal bulk-substance lists, and drug-shortage status.
Newsletter
Pharmacy updates, compounding news and wellness information from the AccuMix team.
By subscribing you agree to receive emails from AccuMix Pharmacy. Unsubscribe at any time.
